soul trial oral semaglutide cardiovascular outcomes 2024 results mace reduction SOUL: Bests Usual Care in High-Risk Type 2 Diabetes SELECT Cardiovascular Trial Information |

Current Content: Is the curriculum updated regularly to reflect new research and guidelines

low blood sugar symptoms if you also take diabetes medication

Semaglutide was estimated to reduce heart disease risk by 18%, potentially preventing 1.5 million cardiovascular events over ten years.1 A healthy body requires a healthy lifestyle, so a balanced diet and exercise are essential

Consider Fermented Foods A healthy gut microbiome is linked to higher natural GLP-1 production

In this interview, Dr Guen Bradbury talks with Dr Helena Rubinstein about how GLP-1 drugs could be as socially disruptive as the smartphones, and how businesses can respond

27 (S2)